keyword
https://read.qxmd.com/read/38052687/colonization-factors-of-human-and-animal-specific-enterotoxigenic-escherichia-coli-etec
#21
REVIEW
Astrid von Mentzer, Ann-Mari Svennerholm
Colonization factors (CFs) are major virulence factors of enterotoxigenic Escherichia coli (ETEC). This pathogen is among the most common causes of bacterial diarrhea in children in low- and middle-income countries, travelers, and livestock. CFs are major candidate antigens in vaccines under development as preventive measures against ETEC infections in humans and livestock. Recent molecular studies have indicated that newly identified CFs on human ETEC are closely related to animal ETEC CFs. Increased knowledge of pathogenic mechanisms, immunogenicity, regulation, and expression of ETEC CFs, as well as the possible spread of animal ETEC to humans, may facilitate the future development of ETEC vaccines for humans and animals...
December 4, 2023: Trends in Microbiology
https://read.qxmd.com/read/38004700/a-first-in-human-clinical-trial-assessing-the-safety-and-immunogenicity-of-two-intradermally-delivered-enterotoxigenic-escherichia-coli-cfa-i-fimbrial-tip-adhesin-antigens-with-and-without-heat-labile-enterotoxin-with-mutation-lt-r192g
#22
JOURNAL ARTICLE
Ramiro L Gutiérrez, Mark S Riddle, Chad K Porter, Milton Maciel, Steven T Poole, Renee M Laird, Michelle Lane, George W Turiansky, Abel Jarell, Stephen J Savarino
INTRODUCTION: Enterotoxigenic E. coli (ETEC) is a leading cause of diarrhea in travelers as well as for children living in low- to middle-income countries. ETEC adhere to intestinal epithelium via colonization factors (CFs). CFA/I, a common CF, is composed of a polymeric stalk and a tip-localized minor adhesive subunit, CfaE. Vaccine delivery by the transcutaneous immunization of dscCfaE was safe but was poorly immunogenic in a phase 1 trial when administered to volunteers with LTR(192G) and mLT...
November 2, 2023: Microorganisms
https://read.qxmd.com/read/37984911/comparison-of-the-effects-of-moxibustion-and-acupuncture-of-combined-biao-ben-acupoints-on-intestinal-sensitivity-and-autonomic-nervous-system-function-in-rats-with-diarrhea-predominant-irritable-bowel-syndrome
#23
JOURNAL ARTICLE
Xu-Liu Zhou, Hua Wang, Song Wu, Jia Li, Fan Wu, Wei Lu, Jia-Wei Zhao, Yi-Hong Li
OBJECTIVES: To compare the effects of moxibustion and acupuncture of combined "Biao-Ben" acupoints (Biao indicates pathogenic factors of disease, Ben refers to body constitution) on a rat model of irritable bowel syndrome with diarrhea (IBS-D). METHODS: Forty female SD rats were randomly divided into 4 groups:normal group, model group, moxibustion group, and acupuncture group, with 10 rats in each group. The IBS-D rat model was established by administering acute-chronic stress combined with folium sennae gavage for 28 days...
November 25, 2023: Zhen Ci Yan Jiu, Acupuncture Research
https://read.qxmd.com/read/37971270/the-potential-for-development-of-clinically-relevant-microbial-resistance-to-rifaximin-%C3%AE-a-narrative-review
#24
REVIEW
Herbert L DuPont
SUMMARYRifaximin-α is a gut-targeted antibiotic indicated for numerous gastrointestinal and liver diseases. Its multifaceted mechanism of action goes beyond direct antimicrobial effects, including alterations in bacterial virulence, cytoprotective effects on host epithelial cells, improvement of impaired intestinal permeability, and reduction of proinflammatory cytokine expression via activation of the pregnane X receptor. Rifaximin-α is virtually non-absorbed, with low systemic drug levels contributing to its excellent safety profile...
December 20, 2023: Clinical Microbiology Reviews
https://read.qxmd.com/read/37970081/duped-by-dumping-syndrome-non-endemic-vibrio-cholerae-bacteremia-in-an-immunocompetent-host-with-gastric-bypass-surgery-a-case-report
#25
Fabiola Reyes, Nicole Pecora, Zoe Freeman Weiss
Extra-intestinal infection with non-O1/non-O139 strains of Vibrio cholerae (NOVC) is rare, though bacteremia and hepatobiliary manifestations have been reported. Reduced stomach acid, or hypochlorhydria, can increase risk of V. cholerae infection. We describe a 42-year-old woman with hypochlorhydria due to untreated Helicobacter pylori infection, gastric-bypass surgery, and chronic proton pump inhibitors (PPI) exposure, who developed acute diarrhoea following raw oyster consumption. Her symptoms were attributed to rapid gastric emptying (dumping syndrome) after a negative limited stool work-up...
2023: Access microbiology
https://read.qxmd.com/read/37945194/a-38-year-old-man-with-persistent-fever-and-progressive-shortness-of-breath
#26
Sathwik Madireddy, Shawn Kim, Argun Can
A 38-year-old man presented to the ED complaining of persistent fever, dry cough, shortness of breath, and diarrhea for 7 days. He reported a history of OSA with inconsistent CPAP use, tobacco use of less than one pack per day, and daily e-cigarette use or "vaping." He denied any contact with ill people or recent travels and was up to date on recommended COVID-19 vaccinations. Prior to his presentation, he had been seen at an urgent care facility twice in the last week, where he was given IV fluids and prescribed steroids without improvement...
November 2023: Chest
https://read.qxmd.com/read/37936503/factors-associated-with-actionable-gastrointestinal-panel-results-in-hospitalized-children
#27
JOURNAL ARTICLE
Erin C Ho, Jillian M Cotter, Jacob Thomas, Meghan Birkholz, Samuel R Dominguez
OBJECTIVES: There is uncertainty regarding which hospitalized patients with acute gastroenteritis (AGE) benefit from gastrointestinal panel (GIP) testing. Unnecessary testing may lead to increased costs, overdiagnosis, and overtreatment. In general, AGE management and outcomes are most impacted if an actionable (bacterial or parasitic) result is obtained. We aimed to assess which clinical reasons for ordering GIP testing ("order indications") and patient factors were associated with actionable results...
November 8, 2023: Hospital Pediatrics
https://read.qxmd.com/read/37926374/investigation-of-human-anthrax-outbreak-in-koraput-district-of-odisha-india
#28
JOURNAL ARTICLE
Debaprasad Parai, Matrujyoti Pattnaik, Hari Ram Choudhary, Arun Kumar Padhi, Swati Pattnaik, Sunita Jena, Subrat Kumar Sahoo, Usha Kiran Rout, Ankita Padhi, Niranjan Sahoo, Sangram Biswal, Soumesh Kumar Padhi, Sanghamitra Pati, Debdutta Bhattacharya
BACKGROUND: Anthrax is a zoonotic infection resulting from the bacteria Bacillus anthracis. Humans contract cutaneous anthrax by coming into contact, and gastrointestinal (GI) anthrax by consumption of infected animals or animal products. An outbreak investigation was conducted to confirm the occurrence of the anthrax outbreak, comprehend its extent, understand the epidemiological characteristics, identify the outbreak's cause, and propose control measures. METHODS: A descriptive epidemiology was carried out for this outbreak investigation...
November 3, 2023: Travel Medicine and Infectious Disease
https://read.qxmd.com/read/37894131/a-polyvalent-adhesin-toxoid-multiepitope-fusion-antigen-induced-functional-antibodies-against-five-enterotoxigenic-escherichia-coli-adhesins-cs7-cs12-cs14-cs17-and-cs21-but-not-enterotoxins-lt-and-sta
#29
JOURNAL ARTICLE
Siqi Li, Hyesuk Seo, Ipshita Upadhyay, Weiping Zhang
The increasing prevalence and association with moderate-to-severe diarrhea make enterotoxigenic Escherichia coli (ETEC) adhesins CS7, CS12, CS14, CS17, and CS21 potential targets of ETEC vaccines. Currently, there are no vaccines licensed to protect against ETEC, a top cause of children's diarrhea and travelers' diarrhea. Recently, a polyvalent adhesin protein (adhesin MEFA-II) was demonstrated to induce antibodies that inhibited adherence from these five ETEC adhesins and reduced the enterotoxicity of ETEC heat-stable toxin (STa), which plays a key role in causing ETEC-associated diarrhea...
October 1, 2023: Microorganisms
https://read.qxmd.com/read/37894071/efficacy-of-an-enterotoxigenic-escherichia-coli-etec-vaccine-on-the-incidence-and-severity-of-traveler-s-diarrhea-td-evaluation-of-alternative-endpoints-and-a-td-severity-score
#30
JOURNAL ARTICLE
Nicole Maier, Shannon L Grahek, Jane Halpern, Suzanne Restrepo, Felipe Troncoso, Janet Shimko, Olga Torres, Jaime Belkind-Gerson, David A Sack, Ann-Mari Svennerholm, Björn Gustafsson, Björn Sjöstrand, Nils Carlin, A Louis Bourgeois, Chad K Porter
The efficacy of an Oral Whole Cell ETEC Vaccine (OEV) against Travelers' Diarrhea (TD) was reexamined using novel outcome and immunologic measures. More specifically, a recently developed disease severity score and alternative clinical endpoints were evaluated as part of an initial validation effort to access the efficacy of a vaccine intervention for the first time in travelers to an ETEC endemic area. A randomized, double-blind, placebo-controlled trial followed travelers to Guatemala or Mexico up to 28 days after arrival in the country following vaccination (two doses two weeks apart) with an ETEC vaccine...
September 27, 2023: Microorganisms
https://read.qxmd.com/read/37885398/-autochthonous-case-of-malaria-prediagnosed-as-leukemia
#31
JOURNAL ARTICLE
Hüseyin Gülen, Ayşe Türedi Yıldırım, İbrahim Çavuş, Hülya Türkmen, Ahmet Özbilgin
Malaria is a parasitic disease transmitted by infected female Anopheles mosquitoes. There are five species of Plasmodium species that can infect humans. Of these species, especially P.falciparum and P.vivax pose the greatest threat to human health. In the 2014 report of the World Health Organization, it was reported that there were no locally acquired cases of malaria in 16 countries including Türkiye. Malaria cases originating from outside the country and imported due to migration, travel and working abroad are reported as import cases...
October 2023: Mikrobiyoloji Bülteni
https://read.qxmd.com/read/37884048/traveler-s-diarrhea
#32
JOURNAL ARTICLE
Justin M Gambini, Elyse Watkins
Traveler's diarrhea (TD) is one of the most common illnesses afflicting the modern traveler. TD refers to a watery diarrhea that varies in severity from tolerable to incapacitating and that develops in individuals during or within 10 days of returning from travel to developing or low-/middle-income countries. Most cases of TD are self-limiting, but in consideration of the ease of international travel, it is important for providers to diagnose and manage TD with the best available evidence.
November 1, 2023: JAAPA: Official Journal of the American Academy of Physician Assistants
https://read.qxmd.com/read/37874163/protein-based-vaccine-candidate-mecvax-broadly-protects-against-enterotoxigenic-escherichia-coli-intestinal-colonization-in-a-rabbit-model
#33
JOURNAL ARTICLE
Ipshita Upadhyay, Shafiullah M D Parvej, Yiyang Shen, Siqi Li, Kathryn L Lauder, Chongyang Zhang, Weiping Zhang
There are no vaccines licensed against enterotoxigenic Escherichia coli (ETEC), a leading cause of children's diarrhea and the most common cause of travelers' diarrhea. Multivalent vaccine candidate MecVax unprecedentedly targets two ETEC enterotoxins (heat-stable toxin, STa; heat-labile toxin, LT) and the seven most prevalent ETEC adhesins (colonization factor antigen, CFA/I, coli surface antigens, CS1-CS6) and has been demonstrated preclinically to protect against STa- and LT-mediated ETEC clinical diarrhea and prevent intestinal colonization from ETEC strain H10407 (CFA/I, STa, LT)...
October 24, 2023: Infection and Immunity
https://read.qxmd.com/read/37870499/advances-on-the-forefront-of-travellers-diarrhoea
#34
JOURNAL ARTICLE
Mark S Riddle, Charles D Ericsson, Robert Steffen
No abstract text is available yet for this article.
October 31, 2023: Journal of Travel Medicine
https://read.qxmd.com/read/37843948/the-ill-returning-traveler
#35
JOURNAL ARTICLE
Nicholas A Rathjen, S David Shahbodaghi
Approximately 1.8 billion people will cross an international border by 2030, and 66% of travelers will develop a travel-related illness. Most travel-related illnesses are self-limiting and do not require significant intervention; others could cause significant morbidity or mortality. Physicians should begin with a thorough history and clinical examination to have the highest probability of making the correct diagnosis. Targeted questioning should focus on the type of trip taken, the travel itinerary, and a list of all geographic locations visited...
October 2023: American Family Physician
https://read.qxmd.com/read/37827969/vaccine-value-profile-for-shigella
#36
JOURNAL ARTICLE
William P Hausdorff, John D Anderson, Karoun H Bagamian, A Louis Bourgeois, Melody Mills, Frederick Sawe, Suzanne Scheele, Kawsar Talaat, Birgitte K Giersing
Shigella is the leading bacterial cause of diarrhoea and the second leading cause of diarrhoeal mortality among all ages. It also exhibits increasing levels of antibiotic resistance. The greatest burden is among children under five in low- and middle-income countries (LMICs). As such, a priority strategic goal of the World Health Organization (WHO) is the development of a safe, effective and affordable vaccine to reduce morbidity and mortality from Shigella-attributable dysentery and diarrhea, including long term outcomes associated with chronic inflammation and growth faltering, in children under 5 years of age in LMICs...
October 10, 2023: Vaccine
https://read.qxmd.com/read/37800954/toxigenic-vibrio-cholerae-strains-in-south-east-queensland-australian-river-waterways
#37
JOURNAL ARTICLE
Murari Bhandari, Irani U Rathnayake, Lawrence Ariotti, Brett Heron, Flavia Huygens, Mitchelle Sullivan, Amy V Jennison
Cholera is a major public health problem in developing and underdeveloped countries; however, it remains of concern to developed countries such as Australia as international travel-related or locally acquired cholera or diarrheal disease cases are still reported. Cholera is mainly caused by cholera toxin (CT) producing toxigenic O1 and O139 serogroup Vibrio cholerae strains. While most toxigenic V. cholerae cases in Australia are thought to be caused by international-acquired infections, Australia has its own indigenous toxigenic and non-toxigenic O1 and non-O1, non-O139 V...
October 6, 2023: Applied and Environmental Microbiology
https://read.qxmd.com/read/37795982/a-broadly-immunogenic-polyvalent-shigella-multiepitope-fusion-antigen-protein-protects-against-shigella-sonnei-and-shigella-flexneri-lethal-pulmonary-challenges-in-mice
#38
JOURNAL ARTICLE
Siqi Li, Shaghayegh Anvari, Galen Ptacek, Ipshita Upadhyay, Robert W Kaminski, David A Sack, Weiping Zhang
There are no licensed vaccines for Shigella , a leading cause of children's diarrhea and a common etiology of travelers' diarrhea. To develop a cross-protective Shigella vaccine, in this study, we constructed a polyvalent protein immunogen to present conserved immunodominant epitopes of Shigella invasion plasmid antigens B (IpaB) and D (IpaD), VirG, GuaB, and Shiga toxins on backbone protein IpaD, by applying an epitope- and structure-based multiepitope-fusion-antigen (MEFA) vaccinology platform, examined protein ( Shigella MEFA) broad immunogenicity, and evaluated antibody function against Shigella invasion and Shiga toxin cytotoxicity but also protection against Shigella lethal challenge...
October 5, 2023: Infection and Immunity
https://read.qxmd.com/read/37787523/the-role-of-the-minor-colonization-factor-cs14-in-adherence-to-intestinal-cell-models-by-geographically-diverse-etec-isolates
#39
JOURNAL ARTICLE
Emily M Smith, Antonia Papadimas, Caitlin Gabor, Ceanna Cooney, Tao Wu, David Rasko, Eileen M Barry
Enterotoxigenic Escherichia coli (ETEC) is a primary causative agent of diarrhea in travelers and young children in low- to middle-income countries. ETEC adheres to small intestinal epithelia via colonization factors (CFs) and secretes heat-stable toxin and/or heat-labile toxin, causing dysregulated ion transport and water secretion. There are over 30 CFs identified, including major CFs associated with moderate-to-severe diarrhea (MSD) and minor CFs for which a role in pathogenesis is less clear. The Global Enteric Multicenter Study identified CS14, a class 5a fimbriae, as the only minor CF significantly associated with MSD and was recommended for inclusion in ETEC vaccines...
October 3, 2023: MSphere
https://read.qxmd.com/read/37771853/the-impact-of-infectious-disease-syndromes-on-activities-during-military-travel
#40
JOURNAL ARTICLE
Michael A Boatwright, Huai-Ching Kuo, David A Lindholm, Tara Griffith, Rhonda E Colombo, David R Tribble, Robert O'Connell, Tahaniyat Lalani
BACKGROUND: We evaluated the impact of infectious disease (ID) syndromes on US active duty (AD) servicemembers returning from overseas deployment (DEP), military training exercises (EXR), or short-term military travel (eg, temporary assignment of duty [TDY]). METHODS: We conducted a survey-based assessment of US AD servicemembers returning from DEP, EXR, or TDY between 2015 and 2019. Subjects completed a post-travel survey capturing symptoms of travelers' diarrhea (TD), influenza-like illness (ILI), and febrile illness (FI)...
September 2023: Open Forum Infectious Diseases
keyword
keyword
113510
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.